National Biotechnology Strategy
KFSHRC Treats 200 Patients with CAR-T Therapy and Launches Local Manufacturing
Riyadh, Saudi Arabia – October 29King Faisal Specialist Hospital and Research Centre (KFSHRC) has treated more than 200 patients with genetically modified T-cell therapy since 2020, targeting aggressive blood cancers resistant to standard treatment. The milestone demonstrates the hospital’s expertise in advanced immunotherapy and aligns with its mission to be the preferred destination for specialized, […]
Nour Elotaiby ·